The Riddell-Swan Veterinary Cancer Centre

Research and developments

The Royal (Dick) School of Veterinary Studies has an international reputation in cancer research, led by Professor David Argyle.

Cancer Research Programme

Our vision is the transformation of clinical practice to improve the health and wellbeing of cancer patients in our care. This involves studies on the basic biology of cancer in dogs and cats, and the translation of that knowledge into clinical practice. We are funded by the BBSRC, EPSRC, Morris Animal Foundation, Petplan Charitable trust and have numerous links with Industry. We have strong collaborations across the cancer research community, both nationally and Internationally. A more complete synopsis of our research can be found at the hyperlink below. However, it can be summarized as follows:

Cancer Research Programme

  • The stem cell basis of cancer and identification of new cancer targets
  • Understanding the process of cancer invasion and metastasis
  • New drug targets for Lymphoma
  • The development of Monoclonal antibody therapy for cancer in dogs and cats
  • Measurement of tumour microenvironment using implantable devices

Clinical Research Programmes

  • The Use of Tyrosine Kinase Inhibitors in cancer
  • Optimum radiotherapy protocols for cancer patients
  • Overcoming the barriers of radiation resistance

Our research group is based within the Roslin Institute and, in addition to our postgraduate residency programme, we also train the next generation of cancer specialist through our PhD programme in cancer biology.